✦ LIBER ✦
Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) comparing TCG with standard TC
✍ Scribed by A. du BOIS; J. SEHOULI; B. LUND; F. JOLY; J. HUOBER; T.S. JENSEN; E. LEVY; V. HEILMANN; K. BOMAN; A.C. HARDY-BESSARD; A. BURGES; J. MÄENPÄÄ; E. PUJADE-LAURAINE; J. PFISTERER; M. GROPP; A. STAEHLE; P. WIMBERGER; C. JACKISCH; B. SCHMALFELDT; A. BELAU; S. LOIBL; K. WOLLSCHLAEGER; U. CANZLER; J. ROCHON; GCIG Intergroup of AGO-OVAR; NSGO;; GINECO
- Book ID
- 109085409
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 36 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1048-891X
No coin nor oath required. For personal study only.